Celltrion Joins Fight Over Takeda Crohn's Treatment Patents
South Korean biopharma company Celltrion Inc. has teamed up with four other generic drugmakers in their claim to knock out a package of patents owned by rival Takeda Pharmaceuticals USA Inc. covering...To view the full article, register now.
Already a subscriber? Click here to view full article